Results 211 to 220 of about 282,884 (313)
27-Hydroxycholesterol in bile duct tissue promotes cholangiocarcinoma progression through estrogen receptor signaling. [PDF]
Konishi N +6 more
europepmc +1 more source
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas +16 more
wiley +1 more source
Rethinking estrogen receptor β in EAOC: a synergistic modulator in a genomically informed landscape. [PDF]
Luo L, Dai W, Cao N, Ye M.
europepmc +1 more source
Aims The aim of this study is to evaluate the effects of multiple doses of esomeprazole, a strong proton pump inhibitor and acid‐reducing agent, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader.
Lana Tran +7 more
wiley +1 more source
Selective estrogen receptor modifiers on the antidepressant-like effects of electroconvulsive seizures in adolescent rats. [PDF]
Garau C +4 more
europepmc +1 more source
PLGA‐based sustained‐release microneedles were developed for the delivery of desogestrel and ethinyl estradiol. The system enabled coordinated release of both drugs, suggesting its potential to improve dosing convenience as a long‐acting contraceptive platform.
Young‐Jin Kim +5 more
wiley +1 more source
Lack of endothelial estrogen receptor alpha signaling exacerbates abdominal aortic aneurysm in male mice. [PDF]
Sharma N +5 more
europepmc +1 more source
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao +4 more
wiley +1 more source

